Filing Details
- Accession Number:
- 0001225208-11-019891
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-15 14:03:49
- Reporting Period:
- 2011-08-12
- Filing Date:
- 2011-08-15
- Accepted Time:
- 2011-08-15 14:03:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226287 | N Peter Kellogg | One Merck Drive Whitehouse Station NJ 08889-0100 | Exe V-P & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-12 | 5,810 | $31.81 | 44,009 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-08-12 | 4,155 | $31.78 | 48,164 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-08-12 | 4,000 | $31.80 | 52,164 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-08-12 | 1,635 | $31.77 | 53,799 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-08-12 | 200 | $31.80 | 53,999 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Holdings include shares acquired in dividend reinvestment transactions.